HOOKIPA Pharma Inc. Quarterly Costs and Expenses in USD from Q3 2018 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: HOOKIPA Pharma Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2018 to Q3 2024.
HOOKIPA Pharma Inc. Costs and Expenses for the quarter ending September 30, 2024 was $23.3M, a 21% decline year-over-year.
HOOKIPA Pharma Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $111M, a 9.86% increase year-over-year.
HOOKIPA Pharma Inc. annual Costs and Expenses for 2023 was $118M, a 34.8% increase from 2022.
HOOKIPA Pharma Inc. annual Costs and Expenses for 2022 was $87.4M, a 12.7% decline from 2021.
HOOKIPA Pharma Inc. annual Costs and Expenses for 2021 was $100M, a 37.4% increase from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$111M	$23.3M	-$6.19M	-21%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$117M	$23.7M	-$403K	-1.67%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$117M	$25.5M	-$340K	-1.32%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$118M	$38.3M	+$16.9M	+78.8%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-22
Q3 2023	$101M	$29.5M	+$6.31M	+27.2%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-14
Q2 2023	$94.6M	$24.2M	+$2.98M	+14.1%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08
Q1 2023	$91.6M	$25.8M	+$4.24M	+19.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	$87.4M	$21.4M	-$4.53M	-17.4%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-22
Q3 2022	$91.9M	$23.2M	-$1.82M	-7.26%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	$93.7M	$21.2M	-$3.49M	-14.2%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$97.2M	$21.6M	-$2.88M	-11.8%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$100M	$25.9M	+$5.59M	+27.4%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-22
Q3 2021	$94.5M	$25M	+$4.59M	+22.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	$89.9M	$24.7M	+$8.76M	+55%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$81.2M	$24.5M	+$8.32M	+51.5%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-16
Q4 2020	$72.9M	$20.4M	+$3.51M	+20.9%	Oct 1, 2020	Dec 31, 2020	10-K	2023-03-15
Q3 2020	$69.4M	$20.4M	+$4.83M	+30.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$64.5M	$15.9M	-$1.77M	-10%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	$66.3M	$16.2M	+$3.27M	+25.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-12
Q4 2019	$63M	$16.8M			Oct 1, 2019	Dec 31, 2019	10-K	2022-03-24
Q3 2019		$15.6M	+$8.16M	+110%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019		$17.7M			Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019		$12.9M			Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-14
Q3 2018		$7.45M			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.